KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Assets (2016 - 2025)

Exact Sciences (EXAS) has disclosed Current Assets for 16 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets fell 0.99% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 0.99% decrease, with the full-year FY2025 number at $1.6 billion, down 0.99% from a year prior.
  • Current Assets was $1.6 billion for Q4 2025 at Exact Sciences, down from $1.6 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.8 billion in Q1 2021 to a low of $982.3 million in Q4 2022.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2021 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: plummeted 35.13% in 2021, then skyrocketed 33.53% in 2024.
  • Exact Sciences' Current Assets stood at $1.4 billion in 2021, then tumbled by 31.13% to $982.3 million in 2022, then increased by 21.59% to $1.2 billion in 2023, then soared by 31.57% to $1.6 billion in 2024, then fell by 0.99% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Current Assets are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.5 billion (Q2 2025).